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SUMMARY

Aneuploidy disrupts cellular homeostasis. However,
the molecular mechanisms underlying the physiological responses and adaptation to aneuploidy are
not well understood. Deciphering these mechanisms
is important because aneuploidy is associated with
diseases, including intellectual disability and cancer.
Although tumors and mammalian aneuploid cells,
including several cancer cell lines, show altered
levels of sphingolipids, the role of sphingolipids in
aneuploidy remains unknown. Here, we show that
ceramides and long-chain bases, sphingolipid molecules that slow proliferation and promote survival,
are increased by aneuploidy. Sphingolipid levels
are tightly linked to serine synthesis, and inhibiting
either serine or sphingolipid synthesis can specifically impair the fitness of aneuploid cells. Remarkably, the fitness of aneuploid cells improves or deteriorates upon genetically decreasing or increasing
ceramides, respectively. Combined targeting of
serine and sphingolipid synthesis could be exploited
to specifically target cancer cells, the vast majority of
which are aneuploid.
INTRODUCTION
Chromosome missegregation events leading to aneuploidy
cause severe developmental defects in organisms (Torres
et al., 2008). In the absence of other genomic alterations, losing
chromosomes is usually lethal to cells whereas gaining chromosomes disrupts cellular homeostasis and hampers proliferation.
At both the cellular and organismal levels, the deleterious effects
of gaining chromosomes correlate with an increased number of
encoding genes (Torres, 2015). However, the effects of aneuploidy on cell physiology can depend on the microenvironment
as aneuploidy can confer a proliferative advantage under stress

conditions or resistance to a particular drug (Pavelka et al., 2010;
Selmecki et al., 2006; Yona et al., 2012). Aneuploidy is a common
characteristic of cancer cells, and gaining or losing chromosomes provides a mechanism by which cells gain copies of
oncogenes or lose tumor suppressor genes, thereby driving
tumorigenesis (Davoli et al., 2013). Importantly, the mechanisms
by which cancer cells overcome the deleterious consequences
associated with aneuploidy are not known.
To investigate how aneuploidy affects cellular physiology in
eukaryotes, we generated and characterized a series of aneuploid yeast strains, each carrying an extra copy of a given chromosome (referred to as disomes; Torres et al., 2007). A direct
consequence of acquiring an extra chromosome is the increased
expression of the duplicated genes (Torres et al., 2016). On
average, duplicated transcripts are translated, leading to proportional increases in protein abundance, with the notable exception of subunits of macromolecular complexes whose stability
depends on complex assembly (Dephoure et al., 2014; McShane
et al., 2016). The general increase in protein synthesis can cause
several phenotypes shared by all aneuploid cells independent of
the identity of the extra chromosome (Oromendia et al., 2012;
Torres et al., 2007). Such phenotypes include decreased proliferation rates, increased glucose utilization, and signs of proteotoxic stress, all of which are also observed in aneuploid human
cells (Santaguida and Amon, 2015; Stingele et al., 2012).
We previously identified aneuploidy-tolerating spontaneous
mutations that improve the fitness of aneuploid cells (Torres
et al., 2010). Among these, loss of function mutation in the deubiquitinating enzyme Ubp6 was shown to improve the fitness
of 4 out of 12 aneuploid strains. Global proteome quantification
revealed that loss of UBP6 leads to the attenuation of the levels
of overexpressed proteins, likely through a general increase in
proteasome activity (Bashore et al., 2015; Dephoure et al.,
2014; Hanna et al., 2006). This provides at least one mechanism
by which altering a cellular process—increasing protein turnover—improves the fitness of aneuploid cells independent of
karyotype.
Among the other aneuploidy-tolerating mutations in yeast
were three independent spontaneous mutations in a gene that
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regulates sphingolipid synthesis (SVF1), implicating these molecules in the physiological responses to aneuploidy (Brace et al.,
2007; Torres et al., 2010). Aneuploid primary mouse embryonic
fibroblasts (MEFs), cancer cell lines, and tumors show elevated
levels of sphingolipids, yet a functional link between changes
in sphingolipid levels and aneuploidy is not known (Erez-Roman
et al., 2010; Guillermet-Guibert et al., 2009; Morad and Cabot,
2013; Tang et al., 2017). Sphingolipids are synthesized from
serine and palmitoyl-coenzyme A (CoA) (Figure 1A). Both longchain bases (LCBs) and ceramides increase rapidly upon stress
and function as signaling molecules (Dickson et al., 1997; Jenkins et al., 1997). Whereas ceramides serve to slow proliferation
by delaying entry into the cell cycle (Nickels and Broach, 1996),
LCBs activate transcriptional responses and signaling pathways
associated with cell wall integrity and survival (Cowart et al.,
2003; Dickson and Lester, 2002). Here, we find that the levels
of both LCBs and ceramides are elevated in aneuploidy and
that increased serine synthesis accounts for the accumulation
of sphingolipids in aneuploid cells. Remarkably, the proliferation
of several aneuploid strains improves significantly upon genetically decreasing the levels of ceramides and increasing those
of LCBs. Transcriptome and proteome analyses of disomes
harboring a mutation that improves their fitness indicate that
sphingolipids regulate membrane protein composition, RNA
biosynthesis, and metabolic pathways associated with energy
production and biosynthesis.
RESULTS
Aneuploid Cells Rely on Increased De Novo Synthesis of
Sphingolipids to Proliferate
To determine how regulation of sphingolipids affects the viability
of aneuploid cells, we treated cells with myriocin, a specific inhibitor of serine palmitoyltransferase (SPT), which catalyzes the
first and rate-limiting step of sphingolipid synthesis (Figure 1A).
We found that 10 out of 13 disomes are hypersensitive to myriocin compared to wild-type cells (IV, V, VIII, IX, X, XI, XII, XIV,
XV, and XVI; Figures 1B and 1C). Four other aneuploid strains
harboring extra copies of either 2 or 3 chromosomes were also
sensitive to myriocin treatment (Figure 1B). Furthermore, we
found that 33 of 35 aneuploid yeast strains derived from random
meiosis and that harbor complex karyotypes are sensitive to
myriocin (Figure S1A; Pavelka et al., 2010). These results indicate
that, despite the phenotypic variability and non-genetic individuality of aneuploid cells (Beach et al., 2017; Pavelka et al., 2010),
the majority of aneuploid strains are sensitive to inhibition of
sphingolipid synthesis, independent of karyotype identity.
Similar sensitivities were not observed in strains carrying yeast
artificial chromosomes (YACs) that contain mammalian DNA
with no known protein-coding genes (Figure 1B), indicating
that enhanced myriocin sensitivity results from increased gene
expression in aneuploid cells rather than increased DNA content.
To determine whether sensitivity to inhibition of sphingolipid
synthesis is a reflection of a more general need for lipids, we
treated cells with cerulenin, an inhibitor of fatty acid synthase.
We found that cerulenin does not specifically affect the viability
of aneuploid cells, suggesting that lipid synthesis, in general, is
not affected by aneuploidy (Figures 1D and S1B). Notably, three
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hypomorphic alleles of essential cell cycle genes that exhibit
reduced proliferation rates at the permissive temperature were
not sensitive to myriocin (Figure 1E), indicating that impaired
proliferation itself does not confer myriocin sensitivity. These results indicate that aneuploid cells rely on increased sphingolipid
production for their viability.
Aneuploid Cells Have Elevated Levels of Long-Chain
Bases and Ceramides
To test whether aneuploidy alters the cellular composition of
LCBs or ceramides, we performed quantitative mass spectrometry (MS) on lipid extracts from 13 disomes as well as wild-type
cells (Table S1; Bielawski et al., 2009). We found that the levels
of LCBs or ceramides are increased in the aneuploid strains
compared to wild-type cells (Figures 1F, 1G, and S1C). Interestingly, disomes with modest cell cycle delays, including disomes
I, II, V, IX, X, and XIII (Torres et al., 2007), exhibited the smallest
increases in ceramide levels (Figure 1G). Indeed, increases in
ceramide levels correlated with decreased proliferation rates
of the disomes (Figure S1D; Pearson r = 0.65; p value = 0.008).
These results support the hypothesis that accumulation of
ceramides plays a role in slowing the cell cycle in response to
aneuploidy.
To investigate whether other lipids also increase in aneuploid
cells, we comprehensively examined the cellular lipid composition using a MS-based global lipidomic technique in several
strains (6 disomes analyzed: V, XI, XII, XIV, XV, XVI, and wildtype cells; Ejsing et al., 2009). These measurements confirmed
a consistent and significant increase in ceramide levels in the
disomes compared to wild-type cells. This is in contrast to
most other lipids, the levels of which were only mildly and inconsistently altered (Figures S1E and S1F; Table S1). Lastly, we
used a third approach based on quantitative high-performance
liquid chromatography (qHPLC) to specifically quantify LCBs
and their phosphorylated forms LCB-Ps (Lester and Dickson,
2001). We validated that the levels of LCBs and LCB-Ps are
elevated in several disomes relative to wild-type cells (5 disomes
analyzed: V, XI, XII, XV, XVI, and wild-type cells; Figures
S1G–S1I; Table S2). Altogether, these results demonstrate, via
three independent methodologies, that the levels of both LCBs
and ceramides are increased in aneuploid cells and indicate
that altered sphingolipid metabolism is a general feature of
aneuploid cells.
Increased Serine Synthesis Accounts for Higher Levels
of Sphingolipids in Aneuploid Cells
We next sought to understand the mechanisms leading to
increased sphingolipid levels in aneuploid cells. Dozens of genes
are involved in the regulation of sphingolipid biosynthesis (Table
S3; Cherry et al., 2012). With the exception of the genes present
in the duplicated chromosomes, mRNA and protein expression
of this network of genes do not show significant differences between disomes and wild-type cells, indicating that transcriptional regulation does not play a significant role in the accumulation of sphingolipids in aneuploid cells (Figures S2A and S2B;
Dephoure et al., 2014). We next examined whether aneuploidy
increases SPT enzymatic activity. We found that, with the exception of disome IV, which contains two copies of the catalytic
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Figure 1. Aneuploidy Increases Sphingolipid Biosynthesis
(A) Biochemical pathway of de novo synthesis of sphingolipids in yeast. Genes used in this study are shown in red. LCB, long-chain bases, asterisk (*) indicates
that LCBs need to be phosphorylated/dephosphorylated to be converted to ceramide; IPC, inositol-phosphorylceramide; MIPC, mannosyl-IPC; M(IP)2C,
mannosyl-diinositol-phosphorylceramide; SPT, serine palmitoyltransferase.
(B) Proliferative capability of wild-type cells (WT), disomes, and strains harboring YAC in the presence of myriocin.
(C) Quantification of the viability of cells treated with 200 ng/mL myriocin in the left panel. Right panel shows the doubling times of disomes in synthetic complete
media alone (SC) (black bars) and with 200 ng/mL myriocin (Myr) (gray bars) relative to WT. Red arrows point to strains that did not grow in culture.
(D) Proliferative capability of WT, disomes, and strains harboring YAC in the presence of cerulenin.
(E) Proliferative capability of WT, cell cycle mutants, and disome VIII in the presence of myriocin (200 ng/mL) and at a restrictive temperature for the cell cycle
mutants.
(F) Liquid chromatography (LC)/LC-MS analysis of LCBs and ceramides in the disomes compared to WT. Columns represent experiments (3 biological replicates
shown). Rows represent lipid species. Cer, ceramide; DH, dihydro; DHS, dihydrosphingosine; PHS, phytosphingosine. Most abundant LCB and ceramide are in
gray boxes.
(G) Fold change of total LCBs and ceramides in the disomes relative to WT.
Error bars represent ± SD. See Supplemental Information for details on the strains used in all figures. See also Figure S1 and Tables S1 and S2.
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subunit of the SPT complex (LCB2), SPT activity is not significantly altered in the disomes compared to wild-type cells (Figures S2C and S2D). This indicates that signaling pathways
known to regulate SPT activity do not play a critical role in the
cellular responses to aneuploidy (Roelants et al., 2011).
Because substrate availability is rate limiting for the de novo
synthesis of sphingolipids (Alvarez-Vasquez et al., 2005; Cowart
and Hannun, 2007), we next examined the serine requirements
for the proliferation of the disomes. We recently identified Ser2,
the phosphoserine phosphatase that catalyzes the final and
rate-limiting step in the synthesis of serine from glucose, to be
upregulated in the disomes, indicating that serine biosynthesis
from glucose may be critical for aneuploid cells (Figures 2A,
2B, S2A, and S2B; Dephoure et al., 2014). Strikingly, deletion
of SER2 significantly hampered the proliferation of all disomes
tested while only causing a modest effect on the proliferation
of wild-type cells (Figures 2C and 2D). Disomes harboring the
largest chromosomes were most affected by ser2D, and four
of these (IV, XIV, XV, and XVI) did not grow in liquid medium.
Standard synthetic medium contains 1 mM serine, a condition
under which the disomes proliferate very poorly. Supplementation of 5 or 10 mM serine significantly improved the proliferation
of the disomes while minimally affecting that of wild-type cells
(Figures 2E and 2F). Addition of other amino acids did not result
in similar effects (Figure S2E). These data indicate that the dis-
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Figure 2. Aneuploid Cells Require Increased
Serine Biosynthesis for Their Survival
(A) Biochemical pathway of de novo serine
synthesis from glucose. Human genes (blue)
and yeast genes (red) are shown. 3PG, 3-phosphoglycerate; P-PYR, phosphohydroxypyruvate;
P-SER, phosphoserine.
(B) Ser2 protein levels in the disomes relative to WT
(Dephoure et al., 2014).
(C) Growth curves of cells with wild-type SER2
(black line) or harboring ser2D (blue line). WT and
disome II are shown.
(D) Doubling times of disomes (black bars) and
disomes harboring ser2D (blue bars) relative to WT.
Red arrows point to strains that did not grow in
culture. Error bars represent ± SD; n = 3.
(E) Growth curves of cells harboring ser2D in
medium containing 1 mM serine (black line), 5 mM
serine (blue line), and 10 mM serine (red line).
(F) Doubling times of disomes harboring ser2D
in medium containing 1 mM (black), 5 mM (blue),
or 10 mM (red) serine. Error bars represent ± SD;
n = 3. Black arrows point to strains that did not
grow in culture.
See also Figure S2 and Table S3.

omes exhibit a higher metabolic demand
for serine and that the lack of serine alone
and not the accumulation of metabolic
intermediates upon SER2 loss of function
is deleterious to aneuploid cells. Similar
results were obtained when the phosphoserine aminotransferase SER1 was
deleted in the disomes (Figure S2F), thus corroborating our
findings.
Increased levels of sphingolipids and higher dependence on
serine synthesis suggest that, compared to euploid cells, aneuploid cells utilize more serine for the production of sphingolipids.
Indeed, we found that despite their impaired proliferation, most
disomes (10 out of 12: I, II, VIII, X, XI, XII, XIII, XIV, XV, and XVI)
have increased serine utilization compared to wild-type cells
(Figures 3A and 3B). To determine whether changes in serine
metabolic flux leads to increased sphingolipid synthesis, we
quantified 14C-serine incorporation into ceramides in wild-type
cells and disomes. Using this approach, we detected increased
serine incorporation into ceramides in 10 out of 12 disomes (I, V,
VIII, IX, X, XI, XII, XIV, XV, and XVI; Figure 3C). The differences in
serine intake account for the increased ceramide synthesis,
because the fold change in serine intake strongly predicts the
fold changes in ceramide levels (Pearson r = 0.7; Figure 3D).
To validate whether impaired serine synthesis affects the synthesis of sphingolipids, we used quantitative MS to measure the
levels of LCBs in four strains harboring the ser2D (wild-type
and 3 representative disomes: V, XI, and XIV; Figure S3A) and
confirmed that indeed LCBs are reduced when serine synthesis
is impaired. These results show that aneuploid cells rely on
increased serine synthesis for their survival and indicate that
increased serine synthesis due to the upregulation of the

B
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E

phosphoserine phosphatase Ser2 is a major path through which
aneuploid cells accumulate sphingolipids.
Impaired Serine Synthesis Enhances Sensitivity to
Inhibition of Sphingolipid Synthesis
Our results raise the possibility that impaired de novo serine
biosynthesis may render cells vulnerable to drugs that target
sphingolipid synthesis. Indeed, we found that loss of either
SER2 or SER1 enhanced sensitivity of all strains to myriocin (Figures 3E and S3B). Serine also serves as a precursor molecule
for the synthesis of nucleotides. Therefore, it is possible that
aneuploid cells show synthetic interaction with ser2D or ser1D
because these cells have increased serine demand for nucleotide biosynthesis. To assess whether nucleotide biosynthesis is
rate limiting for the proliferation of the disomes, we treated cells
with drugs that inhibit dihydrofolate reductase (DHFR) activity,
thereby blocking deoxythymidine monophosphate (dTMP) synthesis from serine (methotrexate and aminopterin; Figure S3C).
Surprisingly, we found that, whereas most disomes are sensitive
to the DNA-damaging agent 4-nitroquinoline 1-oxide (4NQ),
the majority of disomes do not display enhanced sensitivity to
DHFR inhibitors (Figure S3D). Nonetheless, impairing serine

Figure 3. Aneuploid Cells Use Serine for the
Synthesis of Sphingolipids
(A) Growth curves of WT, disome VIII, and disome
XIV are shown in the left panel. Amount of serine
in the medium as a function of time is shown (right
panel).
(B) Serine utilization per cell during exponential
growth of WT and disomes. Error bars represent ±
SD; n = 3 biological replicates.
(C) Relative amount of serine incorporated into
ceramides in the disomes relative to WT. Error
bars represent ± SD; n = 3 biological replicates.
(D) Linear correlation between the fold change in
serine intake and fold change in ceramide synthesis in the disomes.
(E) Proliferative capability of WT, ser2D, disomes,
and the disomes harboring ser2D in the presence
of myriocin.
See also Figure S3.

synthesis did enhance sensitivity to
DHFR inhibitors in the disomes (Figure S3E). Our results indicate that serine
flux into sphingolipid synthesis plays an
important role in the cellular responses
to aneuploidy and that inhibiting serine
biosynthesis can sensitize aneuploid
cells to drugs that target nucleotide or
sphingolipid synthesis.
Reducing Ceramide Synthesis
Improves the Proliferation of
Aneuploid Cells
To investigate the physiological consequences of the altered levels of sphingolipids in aneuploid cells, we performed
epistasis analysis between genes that regulate ceramide synthesis and aneuploidy. If increased ceramide levels serve to slow
cell cycle progression, deleting a gene that lowers ceramide synthesis may enhance the proliferation of aneuploid cells. To test
this hypothesis, we deleted the ceramide synthase LAG1 in 12
disomes and compared the doubling times with and without
the LAG1 deletion (lag1D). Remarkably, we found that loss of
LAG1 enhanced the proliferation of 9 disomes at 30 C (Figure S4A). Consistently, at 37 C, where the difference in proliferation between disomes and wild-type cells is more apparent, all
disomes showed improved proliferation upon loss of LAG1 (Figures 4A and S4B).
SVF1, the gene mutated in evolved isolates of disome XIV
cells, acts in concert with the LCB kinase LCB4 and the
LCB-P phosphatase LCB3 to control the phosphorylation
of LCBs (Brace et al., 2007). The phosphorylation-dephosphorylation cycle of LCBs is required for their proper compartmentalization and acylation by ceramide synthases (Funato et al.,
2003; Qie et al., 1997). Consequently, loss of LCB3, LCB4, or
SVF1 lowers ceramides and may suppress cell cycle defects
in aneuploid cells (Figures S4D and S4E; Mandala et al.,
1998). Remarkably, we found that deletion of any one of these
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Figure 4. Reduced Ceramide Synthesis Improves the Fitness of Aneuploid Cells
(A) Doubling times of disomes (black bars) and disomes harboring lag1D (open bars) relative to WT at 37 C.
(B) Doubling times of disomes (black bars) and disomes harboring lcb3D (open bars) relative to WT at 37 C.
(C) Doubling times of disomes (black bars) and disomes harboring lcb4D (open bars) relative to WT at 37 C.
The average of 3 biological replicates is shown. Error bars represent ± SD. * represents p value < 0.05; paired Student’s t test. See also Figure S4.

three genes suppresses the proliferation defects of several
aneuploid strains. Indeed, in addition to disome XVI, the proliferation of 5 other disomes improved upon deleting SVF1 at
30 C (Figure S4C). Moreover, deletion of LCB3 significantly
improved the proliferation of 7 disomes at 30 C (Figure S4D)
and that of 9 disomes at 37 C (Figure 4B). Furthermore,
whereas LCB4 loss of function did not affect the fitness of
wild-type cells, it significantly improved the fitness of 5 disomes
at 30 C (Figure S4E) and that of 8 disomes at 37 C (Figure 4C).
These results indicate that distinct gene mutations leading to
lowered ceramide synthesis have beneficial effects on the proliferation of the aneuploid strains.
Increased Ceramide Levels Can Be Exploited to Target
Aneuploid Cells
Because ceramides are elevated in the disomes and ceramides
specifically arrest cells in G1 (Figure S5A), we next examined
whether further increases in ceramide levels could be exploited
to kill aneuploid cells. To this end, we performed three different
genetic approaches that can result in elevated ceramide levels.
First, we analyzed the consequences of deleting CSG2, a protein
that regulates the synthesis of complex sphingolipids (Beeler
et al., 1997). We found that 9 out of 12 disomes harboring
csg2D show impaired fitness and that their proliferation is significantly affected at 37 C (Figure 5A). Second, we examined the
effects of inhibiting the hydrolysis of sphingolipids by deleting
the LCB lyase DPL1 (Cowart et al., 2010; Saba et al., 1997).
We found that loss of DPL1 is deleterious to the majority of the
disomes (9 out of 12 disomes; Figure S5B). Lastly, we examined
the effects of deleting the ceramidase YPC1 and found that this
deletion reduces the fitness of four disomes (I, VIII, XII, and XVI;
Figure S5C). We hypothesize that expression of the other yeast
ceramidase YDC1 may compensate for the loss of YPC1. We
could not test the effects of deleting both ceramidases due to
lethality to yeast.
To validate these findings, we compared the viability of cells
grown in rich medium alone or in the presence of 20 mM C2-ceramide. We found that the proliferation of the majority of the
disomes is impaired compared to wild-type cells in the presence
of C2-ceramide (IV, V, VIII, X, XI, XII, XIII, XIV, XV, and XVI; Fig-
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ure S5D). We next examined the effects of increasing ceramide
levels in the disomes by inhibiting their conversion to complex
sphingolipids by treating cells with aureobasidin A, a specific
inhibitor of AUR1, the inositol phosphorylceramide synthase
(Nagiec et al., 1997). We found that most disomes are hypersensitive to this drug compared to wild-type cells (IV, V, VIII, IX, XI,
XII, XIV, XV, and XVI; Figure S5E). These results demonstrate
that the majority of aneuploid strains are sensitive to drugs that
elevate ceramide levels, with a few exceptions. Given the
complexity and number of genes involved in the regulation of
ceramide synthesis, expression of one or more genes on the
duplicated chromosomes may confer resistance to these drugs
or help cells tolerate increases in ceramide levels.
In sum, our studies reveal that loss of function of either LAG1,
LCB3, LCB4, or SVF1, which leads to increased LCB and lowered ceramide levels, improves the proliferation of the majority
of aneuploid strains; in contrast, increasing ceramide levels
either genetically or pharmacologically decreases their fitness
(Figure 5B). The concomitant increase in the production of
LCBs and ceramides in response to aneuploidy supports the hypothesis that ceramides slow down the proliferation of aneuploid
cells whereas LCBs promote their survival.
Loss of LCB3 Remodels Membrane Protein Composition
of Aneuploid Cells
To gain mechanistic insight into how sphingolipids improve the
fitness of aneuploid cells, we analyzed the transcriptome profiles
of 10 disomes harboring lcb3D compared to wild-type cells (Figure 6A; Table S4). We focused on the effects of LCB3 loss for two
reasons: (1) competition assays revealed that whereas the
fitness of wild-type cells is not affected by lcb3D, that of 9 disomes improved significantly at 30 C (Figure S6A) and (2) MS
measurements revealed that loss of LCB3 restores ceramide
levels close to those of wild-type while significantly increasing
LCB levels (Figures S6B and S6C). This allows us to determine
gene expression changes mainly driven by increases in LCBs.
In addition, we included in our analysis the transcriptional profiles of 13 disomes without any deletions (LCB3, UBP6) and 13
disomes harboring ubp6D (Dephoure et al., 2014). We refer to
the latter 26 strains as control strains.

A

B

Figure 5. Effects of Shifting the Balance between Ceramide and
Long-Chain Bases in Aneuploid Strains
(A) Doubling times of disomes (black bars) and disomes harboring csg2D
(open bars) relative to WT at 37 C. The average of 3 biological replicates
is shown. Error bars represent ± SD. * represents p value < 0.05; paired
Student’s t test.
(B) Summary of the effects of several gene deletions and drugs that target the
synthesis of sphingolipids on the fitness of thirteen disomes.
See also Figure S5.

We found that 62% of the transcriptome of the disomes with
lcb3D show significant changes compared to wild-type cells
(3,107 of 5,016 genes). Sorting by intensities, we identified
groups of genes with similar profiles and categorized them into
several clusters (Figure 6B; see Supplemental Experimental Procedures). Cluster 1 includes 655 genes that are upregulated in
the control strains but are significantly attenuated upon loss of
LCB3. Cluster 2 includes 624 genes whose expression is not
altered in the control strains but are downregulated by the
lcb3D. Gene Ontology enrichment (GO) analysis revealed that
genes encoding membrane proteins are significantly enriched
in clusters 1 and 2 (n = 496; p value = 8E 26; Table S4). Among
these are several transmembrane transporters (n = 145; p value =
5E 08; Table S4). Notable downregulated genes include ATPbinding cassette (ABC) transporters and transporters of metabolites, such as amino acids, uracil, copper, and phosphate.
LCBs, whose levels increase upon loss of LCB3, are known
to downregulate nutrient intake by mechanisms that are not
fully understood (Chung et al., 2001; Skrzypek et al., 1998).
Our results indicate that transcriptional regulation of transporters
is one mechanism by which LCBs regulate nutrient intake.

Loss of LCB3 Upregulates Genes Involved in
Transcription and Metabolic Processes
Cluster 3 includes 533 genes that do not significantly change
in the disomes but are upregulated by lcb3D. Cluster 4 includes
657 genes that are downregulated in the disomes, and their
levels increase upon loss of LCB3. GO analysis revealed a significant enrichment for genes encoding proteins that localize to the
nucleus in these clusters (n = 558; p value = 3E 17), including
nucleolar proteins (n = 96; p value = 3E 06) and proteins that
regulate RNA biosynthesis (n = 361; p value = 7E 11; Figure 6B;
Table S4). In addition, within the most upregulated genes, we
found a significant enrichment for those that regulate metabolic
processes, including mitochondrial genes (p value = 1E 06). Our
results indicate that accumulation of LCBs upon loss of LCB3
activates signaling pathways that drive the described transcriptional changes, raising the hypothesis that changes in
sphingolipids improve the fitness of aneuploid cells by altering
membrane physiology, promoting RNA biosynthesis, and
affecting metabolic functions. Notably, genes whose levels increase or decrease in all 36 aneuploid strains are associated
with a transcriptional response termed the environmental stress
response and are not affected by the loss of LCB3 in the disomes
(Gasch et al., 2000).
Consequences of LCB3 Loss of Function on Cellular
Protein Composition of Aneuploid Cells
To gain further insight into how sphingolipids improve fitness of
aneuploid cells, we used tadem mass tag (TMT)-based quantitative mass spectrometry to determine the proteome profiles of 10
disomes harboring lcb3D (72% of verified open reading frames
[ORFs]; n = 3,682; Table S5). As previously shown for the control
strains, we found that, on average, increases in gene copy number lead to proportional changes in protein levels in 10 disomes
analyzed, all harboring lcb3D (Figure 7A). In addition, we found
that protein levels of duplicated genes that code for subunits
of macromolecular complexes are attenuated to the same extent
as in the control strains (Figure S7A).
To reveal the most relevant changes in protein levels elicited
by the loss of LCB3, we sorted by the averaged log2 ratios and
identified a subset of proteins that specifically change in the disomes upon loss of LCB3 (Figure 7B). We found that 655 and 290
proteins are upregulated and downregulated, respectively, in the
disomes harboring lcb3D. Consistent with the transcriptome
analysis, we found that the subset of downregulated proteins
is enriched for membrane proteins whereas those that are upregulated are significantly enriched for metabolic processes (Figure 7B). GO term analysis of the upregulated proteins revealed
more specific cellular processes than the transcriptome analysis
because as much as 58% (383 proteins) of the upregulation in
protein levels takes place independent of transcription. Remarkably, several metabolic pathways associated with cellular anabolism and energy production were induced by the loss of LCB3
(Figure 7B). Among the most enriched proteins were enzymes
involved in gluconeogenesis, the tricarboxylic acid cycle (TCA)
and glyoxylate cycles, trehalose and glycogen biosynthesis
and breakdown, and ATP synthesis. In addition, among the
most upregulated proteins was Hsp12, a membrane protein
involved in maintaining membrane integrity and required for
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A
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Figure 6. Loss of LCB3 Remodels Membrane Protein Composition and Promotes
RNA Biosynthesis
(A) Gene expression analysis of disomes harboring
lcb3D grown in batch culture, ordered by chromosome position. Experiments (columns) are ordered by the number of the chromosomes present
in two copies. Data were normalized to account for
the extra chromosome present in disomic strains.
Upregulated genes are shown in yellow and
downregulated ones in blue.
(B) Gene expression of disomes, disome harboring
ubp6D, and disomes harboring lcb3D. Columns
represent experiments. Rows are genes organized by pattern of expression of disomes-lcb3D
compared to the control strains (13 disomes and
13 disomes-ubp6D). Top two clusters are up- and
downregulated in all 36 strains. Clusters 1 and 2
are downregulated by lcb3D. Clusters 3 and 4
are upregulated by lcb3D. See Table S4 for GO
enrichment analysis details.
See also Figure S6 and Table S4.

dietary-restriction-induced lifespan extension (Herbert et al.,
2012). These results are consistent with our conclusions from
the transcriptome analysis and indicate that LCBs improve the
fitness of aneuploid cells through transcriptional and posttranscriptional mechanisms to remodel membrane protein composition and promote metabolic pathways associated with anabolism and ATP synthesis.
Importantly, loss of LCB3 did not attenuate the levels of overexpressed proteins in the disomes, indicating that the mechanisms by which changes in sphingolipids improve the fitness of
aneuploid cells are distinct from those induced by the loss of
UBP6 (Figure S7B). In support for this, we found that concomitant loss of UBP6 and LCB3 enhances the fitness of aneuploid
cells to a greater extent than the loss of either alone, indicating
a cooperation between both gene deletions (Figure S7C).
DISCUSSION
Aneuploidy Increases De Novo Synthesis of
Sphingolipids
Here, we found that aneuploid cells accumulate higher levels of
LCBs and ceramides and that this accumulation plays a key role
in the cellular response to aneuploidy. Our studies support the
hypothesis that LCBs activate survival pathways and ceramides
function to slow down cell cycle progression in response to
aneuploidy. Remarkably, we found that the changes in lipid
composition elicited by aneuploidy are specific to sphingolipids
rather than any other lipid class. Furthermore, we provide the
important finding that changes in sphingolipid levels are driven
by increased serine biosynthesis, which itself is driven by
enhanced glucose utilization and upregulation of the Ser2 protein levels. In addition, we found that decreased serine synthesis
significantly alters sphingolipid composition, indicating that
sphingolipid levels are sensitive to the amount of intracellular
serine available for their synthesis. These results indicate that
altered serine metabolic demand can elicit dramatic physiological responses associated with sphingolipid biology. Serine
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serves as a precursor molecule for nucleotides, amino acids,
and other lipids, and its synthesis is increased in a large proportion of human tumors (Locasale et al., 2011; Possemato et al.,
2011). In cancer, it is recognized that serine fuels metabolic pathways associated with the one-carbon cycle (Locasale, 2013).
Here, we demonstrate that, as compared to euploids, aneuploid
cells are dependent on increased serine utilization, which can
lead to altered sphingolipid content and improved cellular
fitness. As a result, serine and sphingolipid synthesis represent
an important metabolic dependency of aneuploid cells.
Lowering Ceramides Improves the Fitness of Aneuploid
Cells
Inhibition of the synthesis of both LCBs and ceramides by myriocin treatment is lethal to aneuploid cells. However, lowering ceramide synthesis while increasing LCB enhances their proliferation. These results suggest that aneuploid cells strictly rely on
the survival functions of LCBs. If ceramide slows down the cell cycle, why would aneuploid cells accumulate higher levels of this
molecule? Endogenous levels of LCBs are coupled to those of
ceramides, as these molecules are generated from each other
and are in a physiological balance. As it happens in response to
extrinsic stresses, both the ‘‘good’’ (LCBs) and the ‘‘bad’’ (ceramide) lipids increase in response to aneuploidy. Thereby, higher
ceramide levels may increase the selective pressure to acquire
mutations to lower their synthesis. Lipidomics measurements
indicate that the combined cellular amounts of LCBs and ceramides are two orders of magnitude lower than their products, the
complex sphingolipids (0.1% versus 15% of total lipids; Figure S1). This suggests that a high metabolic flux exists through
the pathway and that minor changes in enzyme activities or substrate concentrations could lead to significant changes in the
levels of LCBs and ceramides. Four enzymatic activities control
the interconversion of LCBs and ceramides, each encoded by
at least 2 genes: LCB kinase (LCB4 and LCB5); LCB-P phosphatase (LCB3 and YRS3); ceramide synthase (LAG1 and LAC1); and
ceramidase (YPC1 and YDC1). Given this genetic redundancy, we
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Figure 7. Loss of LCB3 Remodels Membrane Protein Composition and Promotes
Anabolism and Mitochondrial Function
(A) The plots show the log2 ratio of the relative
protein abundance of disomes-lcb3D compared
to WT. Protein levels are shown in the order of the
chromosomal location of their encoding genes.
Protein levels of duplicated chromosomes are
shown in red.
(B) Transcript and protein abundances of genes
that are specifically up- and downregulated in the
disomes upon the loss of LBC3. See Table S5 for
GO enrichment analysis details.
See also Figure S7 and Table S5.
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golipids regulate many aspects of cellular
physiology. Because the lcb3 deletion (1)
improves the fitness of aneuploid cells
B
without affecting wild-type cells and (2)
increases LCB levels while restoring ceramide levels closer to those of wild-type
levels, we were able to identify specific
272
cellular processes affected by LCBs in
Metabolic pathways
Gluconeogenesis (Pck1, Mdh2)
aneuploid cells. Nearly 50% of the cellular
Trehalose (Tsl1, Tps1/2, Pgm2, Nth1)
transcriptome is affected in the disomes
Glycogen (Gsy1/2, Glc3, Glc8, Gdb1, Gph1)
when LCB3 is deleted. We found that
TCA cycle (Cit1, Aco2, Idh1, Kgd1, Mdh1/2, Sdh1)
nutrient transporters are transcriptionally
Glyoxylate
cycle
(Icl1,
Mls1,
Dal7)
383
ATP synthesis (Atp3/714/15)
downregulated by LCBs, indicating that
Oxidative phosphorylation (Complex I, II, III, IV)
transcription factors can act downstream
of LCBs. Counter-intuitively, restriction of
nutrient intake could be beneficial for
aneuploid cells. In a manner similar to
75
how dietary restriction promotes metaMembrane proteins
bolic changes contributing to increased
Transmembrane transport
longevity and resistance to stress
215
(amino acids, ions, metabolites)
(Fontana et al., 2010), remodeling the
cell’s membrane protein composition in
mRNA
protein
aneuploid cells may promote metabolic
pathways associated with biosynthesis
lcb3∆
and energy production. These metabolic
changes in turn are beneficial to aneufound that reducing ceramide levels while increasing those of ploid cells because gaining an extra chromosome increases
LCBs (through deletion of one of two genes that hamper LCB ki- the metabolic demands driven by enhanced transcription and
nase activities, LCB-P phosphatase or ceramide synthase) im- protein synthesis, folding, and turnover. Consistently, loss of
proves the fitness of aneuploid cells. Increasing ceramide levels LCB3 or LAG1 (longevity assurance gene) induces resistance
by lowering ceramidase activity has the opposite effect. Interest- to stress and increases lifespan in yeast (D’mello et al., 1994;
ingly, most of the deletions included in our studies have little effect Skrzypek et al., 1999). Our results provide important insights
on the proliferation of wild-type cells under non-stress conditions. into the molecular mechanisms by which several mutations in
This suggests that the genetic redundancy of this essential the sphingolipid pathway can promote longevity and enhance
pathway that is conserved and expanded in humans—where at resistance to stress.
The mechanisms by which loss of LCB3 improve the fitness of
least 6 different genes code for ceramide synthases and 5 for
ceramidases (Coant et al., 2017; Wegner et al., 2016)—allows aneuploid cells are distinct from those elicited by the loss of
flexibility of regulation during cellular responses to stress.
UBP6. This highlights the complexity of the cellular responses
to aneuploidy and indicates that parallel pathways can be acted
upon to overcome the negative effects of aneuploidy. It is imporLong-Chain Bases Promote Anabolism and Energy
Production in Aneuploid Cells
tant to note that the fitness of the disomes harboring both deleIdentifying a specific cellular process affected by changes in tions is lower than that of wild-type cells, indicating that other
sphingolipid levels is experimentally challenging, because sphin- mutations could be acquired to further improve fitness.
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Targeting Sphingolipids in Human Diseases
Aneuploid primary MEFs, cancer cell lines, and human tumors
show elevated levels of sphingolipids. Despite numerous studies
exploiting this correlation to target cancer cells, a general mechanism explaining how cells accumulate higher levels of sphingolipids is lacking. Here, we show that aneuploidy increases the
biosynthesis of sphingolipids and that aneuploid cells are highly
dependent on serine and sphingolipid synthesis. This metabolic
codependency could therefore be exploited therapeutically
to specifically target cancers, the vast majority of which are
aneuploid. Furthermore, individuals with Trisomy 21 suffer from
several immunological disorders, increased risk for leukemias,
premature aging, and neurodegenerative disorders, such as
Alzheimer’s disease. Consequently, our results also provide a
novel framework to study the mechanisms affecting sphingolipid
metabolism in Down syndrome patients.
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EXPERIMENTAL PROCEDURES
Yeast Strains and Growth Conditions
All stains are derivatives of W303 (E187). Detailed methodologies, a list of
strains, and media conditions are provided in Supplemental Experimental
Procedures.
Growth Rate Measurements
All cells were grown overnight to optical density 600 (OD600) between 0.5 and 2
and then diluted to a starting OD600 of 0.2 in 100 mL of fresh medium in 96-well
plates. Cell growth was monitored using a Tecan Infinite PRO microplate
reader at indicated temperatures with continuous shaking. Relative doubling
times (DTs) are simply the ratio of the DT of the strain divided by the DT of
the WT measured in identical experimental conditions.
Mass Spectrometry of Sphingolipids
Lipidomics of wild-type cells and thirteen disomes were outsourced to the
Lipidomics Shares Resource at the Medical University of South Carolina. Cells
were treated with 5% trichloroacetic acid for 10 min on ice and washed with
water 3 times before shipping in dry ice. Three independent cultures were
analyzed for each strain, and relative levels of all lipids were normalized to total
cell numbers, which were determined using a Beckman Coulter Counter. Protocols for lipid extraction and analysis are described in Bielawski et al. (2009).
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